Atlas Venture Associates IX, LLC - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 30 filers reported holding SURFACE ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Atlas Venture Associates IX, LLC ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$2,562,544
+24.3%
2,945,4530.0%14.02%
+44.9%
Q1 2023$2,061,817
-14.6%
2,945,4530.0%9.68%
-19.5%
Q4 2022$2,415,271
-21.1%
2,945,4530.0%12.02%
+32.4%
Q3 2022$3,063,000
-36.6%
2,945,4530.0%9.08%
-17.3%
Q2 2022$4,831,000
-44.2%
2,945,4530.0%10.98%
+37.8%
Q1 2022$8,660,000
-38.5%
2,945,4530.0%7.96%
+29.6%
Q4 2021$14,079,000
-36.9%
2,945,4530.0%6.14%
-17.1%
Q3 2021$22,297,000
+1.5%
2,945,4530.0%7.41%
+91.7%
Q2 2021$21,972,000
-4.4%
2,945,4530.0%3.87%
+0.2%
Q1 2021$22,974,000
-15.6%
2,945,4530.0%3.86%
-10.5%
Q4 2020$27,216,000
-15.1%
2,945,453
-36.6%
4.31%
-87.0%
Q3 2020$32,054,000
+5.2%
4,645,4530.0%33.16%
+1.7%
Q2 2020$30,474,000
+250.8%
4,645,4530.0%32.59%
+77.4%
Q1 2020$8,687,000
-0.5%
4,645,4530.0%18.37%
+20.7%
Q4 2019$8,733,000
+32.4%
4,645,4530.0%15.22%
+40.1%
Q3 2019$6,597,000
-49.6%
4,645,4530.0%10.86%
-22.5%
Q2 2019$13,100,000
-40.9%
4,645,4530.0%14.01%
-32.7%
Q1 2019$22,159,000
+12.5%
4,645,4530.0%20.82%
-8.2%
Q4 2018$19,697,000
-61.2%
4,645,4530.0%22.68%
-15.7%
Q3 2018$50,821,000
-32.9%
4,645,4530.0%26.90%
-19.3%
Q2 2018$75,767,0004,645,45333.35%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$27,216,0004.31%
Atlas Venture Associates XI, LLC 2,945,453$27,216,0004.31%
ACUTA CAPITAL PARTNERS, LLC 999,500$9,235,0002.51%
COMMODORE CAPITAL LP 467,796$4,322,0002.35%
Ghost Tree Capital, LLC 1,000,000$9,240,0002.06%
VR Adviser, LLC 1,442,895$13,332,0001.96%
SILVERARC CAPITAL MANAGEMENT, LLC 130,000$1,201,0000.70%
Parkman Healthcare Partners LLC 175,792$1,624,0000.42%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 26,732$247,0000.39%
One68 Global Capital, LLC 15,071$139,0000.28%
View complete list of SURFACE ONCOLOGY INC shareholders